Anika Therapeutics reported $584.51M in Market Capitalization for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 212.3B 18.24B
Acceleron Pharma XLRN:US $ 8.22B 514.54M
Acorda Therapeutics ACOR:US $ 46.22M 13.12M
Adamas Pharmaceuticals ADMS:US 123.49M 6.97M
Agenus AGEN:US $ 556.74M 47.93M
Agios Pharmaceuticals AGIO:US $ 3.61B 602.58M
Anika Therapeutics ANIK:US $ 584.51M 58.84M
Arrowhead Research ARWR:US $ 6.88B 1B
Chemocentryx CCXI:US $ 3.57B 711.78M
Clovis Oncology CLVS:US $ 733.8M 309.87M
Dicerna Pharmaceuticals DRNA:US $ 1.95B 298.29M
Enanta Pharmaceuticals ENTA:US $ 994.88M 149.55M
Flexion Therapeutics FLXN:US $ 446.82M 122.28M
Halozyme Therapeutics HALO:US $ 5.77B 2.17B
Heron Therapeutics HRTX:US $ 1.48B 441.41M
Immunogen IMGN:US $ 1.26B 524.68M
Insmed INSM:US $ 3.52B 96.4M
Integra Lifesciences IART:US $ 5.84B 367.67M
Intrexon XON:US $ 1.42B 469.52M
Johnson & Johnson JNJ:US $ 432685.32M 18375.76M
Karyopharm Therapeutics KPTI:US $ 789.65M 349.69M
Ligand Pharmaceuticals LGND:US $ 2.53B 933.28M
Macrogenics MGNX:US $ 1.79B 507.01M
Merit Medical Systems MMSI:US $ 3.33B 251.32M
Peregrine Pharmaceuticals PPHM:US $ 1.11B 410.09M
Rigel Pharmaceuticals RIGL:US $ 581.81M 9.62M
Sangamo Biosciences SGMO:US $ 1.8B 406.46M
Sanofi SAN:FP 106.07B 6.99B
Stryker SYK:US $ 91.77B 315.5M
Surmodics SRDX:US $ 771.28M 175.84M
Veracyte VCYT:US $ 2.83B 999.56M
Xencor XNCR:US $ 2.5B 9.58M
Zimmer Biomet Holdings Inc ZBH:US $ 33.35B 1.41B